[177Lu]Lu-ABY-271
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [177Lu]Lu-ABY-271, covering 2025-10-01 to 2025-10-01. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer [Phase 1]